Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 9 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 10.2 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 9.93 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 10.6 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 7.25 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 6.25 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 7.8 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 9.41 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 0.0 | BCD100322A001 | 8.39 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 0.5 | BCD100322A003 | 6.87 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 1.0 | BCD100322A007 | 7.47 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 2.0 | BCD100322A011 | 6.37 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 4.0 | BCD100322A015 | 6.61 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 8.0 | BCD100322A019 | 7.26 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 12.0 | BCD100322A023 | 10.2 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 24.0 | BCD100322A027 | 7.3 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 10.6 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 11.8 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 7.43 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 9.26 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 9.36 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 7.41 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 9.07 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 5.5 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 1.0 | BCD100322A008 | 7.46 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 2.0 | BCD100322A012 | 5.46 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 4.0 | BCD100322A016 | 6.2 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 7.48 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 8.25 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 7.21 | pmol/sample |